Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomecompanyCISAPRIDEMONOHYDRATE
CISAPRIDEMONOHYDRATE
CISAPRIDEMONOHYDRATE

CISAPRIDEMONOHYDRATE

Price USD1.00
Packge 1g
  • Min. Order:1g
  • Supply Ability:20 tons
  • Time:2021-01-06

Product Details

  • Product NameCISAPRIDEMONOHYDRATE
  • CAS No.260779-88-2
  • EINECS No.623-862-5
  • MFC23H31ClFN3O5
  • MW483.97
  • Appearancesolidwhite
  • Water Solubility Water: Insoluble
  • storage temp. Store at -20°C
Product Name: CISAPRIDEMONOHYDRATE
Synonyms: Cisapride (jan);D02092;Propulsid (tn);Cisapride monohydrate,cis-4-Amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenxamide monohydrate, Acenalin, Cipril;Cisapride (200 mg);4-aMino-5-chloro-N-((3R,4S)-1-(3-(4-fluorophenoxy)propyl)-3-Methoxypiperidin-4-yl)-2-MethoxybenzaMide hydrate;BenzaMide,4-aMino-5-chloro-N-[(3R,4S)-1-[3-(4-fluorophenoxy)propyl]-3-Methoxy-4-piperidinyl]-2-Methoxy-,hydrate (1:1), rel-;cis-4-Amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenxamide monohydrate
CAS: 260779-88-2
MF: C23H29N3O4ClFH2O
MW: 0
EINECS: 623-862-5
Product Categories:  
Mol File: 260779-88-2.mol

Company Profile Introduction

Technology research and transfer of pilot screening, pilot scale-up and mass production solutions , for pharmaceutical intermediates, biologicals and fine chemicals (Not including inflammable , explosive , hazardous goods ) ; Market : Nano material , metal catalyst , raw material of cosmetics , pharmaceutical intermediates , chemicals , photoelectric material , import and export of technology and goods (For projects subject to approval according to law, business activities can be carried out only after approval by relevant departments ).
  • Since:2020-12-17
  • Address: Room 702, Floor 7, Building 10, National University Science Park, High-Tech Zone, Zhengzhou City, He
INQUIRY